Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-24T14:57:42.159Z Has data issue: false hasContentIssue false

Review of studies of ADHD: Long-term outcomes with and without treatment

Published online by Cambridge University Press:  16 April 2020

M. Shaw
Affiliation:
Shire Pharmaceuticals, Ltd., Basingstoke, UK
H. Caci
Affiliation:
Hôpitaux Pédiatriques de Nice, Nice, France
P. Hodgkins
Affiliation:
Shire Development Inc., Wayne, PA, USA
J. Kahle
Affiliation:
BPS International, San Diego, CA, USA
N. Callamaras
Affiliation:
BPS International, San Diego, CA, USA
A. Woods
Affiliation:
Shire Development Inc., Wayne, PA, USA

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

As awareness of ADHD has increased worldwide, interest has grown beyond the constellation of ADHD symptoms, to include long-term impact on people's lives and society in general.

Objectives

Examine the results of studies of long-term life consequences of ADHD.

Aims

To identify areas of life affected long-term by ADHD and differences in outcomes with and without ADHD treatment.

Methods

Following Cochrane guidelines, 12 databases were searched for studies published in English (1980–2010). Limiting criteria maximized study inclusion while maintaining high study rigor: (1) peer-reviewed, (2) primary study reports, (3) including a comparator condition, and (4) reporting long-term outcomes (mean 8 years, range 6 months-40 years from study start for prospective studies; subjects in adolescence or adulthood for retrospective or cross-sectional studies). The fully-defined electronic search yielded 4615 citations. Manual review based on titles and abstracts yielded 340 studies included in this analysis of outcomes.

Results

The majority of studies (86%, 243 of 281; studies of untreated ADHD only) showed that untreated ADHD has substantial negative long-term outcomes, encompassing nine broad-ranging areas of life: non-medicinal drug use/addictive behaviour, antisocial behaviour, academic achievement, occupational achievement, public services use, self-esteem, social function, obesity, and driving outcomes. In contrast, most studies including ADHD pharmacotherapy and/or non-pharmacotherapy (94%, 46 of 49) showed that compared with baseline or untreated ADHD, long-term outcomes improved or stabilized with treatment of ADHD.

Conclusions

ADHD has notable negative long-term consequences, and this negative impact may be reduced with treatment of ADHD. Supported by Shire Development Inc.

Type
P01-575
Copyright
Copyright © European Psychiatric Association2011
Submit a response

Comments

No Comments have been published for this article.